HSA-2023-0012-V012

Type IA variation for application HSA-2023-0012. Type IA variation: Labeling Change for Respiralimab — major revision

Variation Number
HSA-2023-0012-V012
Type
Type IA
Application
HSA-2023-0012
Change
CHG-2021-0012
Status
Overdue
Fee
€1,446
Submitted
—
Approved
—
Description

Type IA variation: Labeling Change for Respiralimab — major revision